Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists.
Tamamura H, Hiramatsu K, Mizumoto M, Ueda S, Kusano S, Terakubo S, Akamatsu M, Yamamoto N, Trent JO, Wang Z, Peiper SC, Nakashima H, Otaka A, Fujii N.
Tamamura H, et al. Among authors: trent jo.
Org Biomol Chem. 2003 Nov 7;1(21):3663-9. doi: 10.1039/b306613b.
Org Biomol Chem. 2003.
PMID: 14649897